Delivery Order SPE2DB20D3103-SPE2DB22FM1L0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,371.77 firm-fixed-price delivery order is for the supply of Isosulfan Blue 1% Vial 5mL, a medical product used in various medical procedures. The contract has an ultimate completion date of October 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,083.07 fixed-price delivery order is for the supply of 4562070403 - Isosulfan Blue 1% Vial 5ML, with a completion date of September 7, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $23,290.55 firm fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. This contract is not set aside for any specific business type. The award is a part of Amerisourcebergen's larger Indefinite Delivery...
- This federal contract award, with the ID SPE2DB20D7061|SPE2DB24FSPX7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $17,667.13 firm-fixed-price delivery order is for the supply of 4,565,866,557 units of Isosulfan Blue 1% Vial 5mL, a specialty pharmaceutical product. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of Isosulfan Blue 1% Vial 5ML. The $47,858.81 firm fixed price contract has a completion date of September 27, 2024. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, such as a $999,999,999 IDC with DLA Troop Support Medical valid through December 2025, and a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Isosulfan Blue 1% Vial 5ML to the Defense Logistics Agency (DLA). The contract, valued at $18,313.93, was awarded on December 16, 2021, with a completion date of December 17, 2021. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $7,356.52 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4,566,185,907 units of 1% isosulfan blue dye vials (5 ml). This delivery order is a part of a larger indefinite delivery contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award, with ID SPE2DB20D3505|SPE2DB21FU1L6, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,543.46 delivery order is for pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award, with the ID SPE2DB20D1004|SPE2DB21FF6L3, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of pharmaceutical products and medical supplies. The $6,085.64 delivery order is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,066.32 Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM1L0Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FM1L0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,942.15 firm-fixed-price delivery order is for the supply of 4555811271 - ISOSULFAN BLUE 1% VIAL 5ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/30/21 |